saline in 2.5% dextrose and 300 ml of Haemaccel, in the Accident and Emergency Department, via a 22 gauge cannula. Examination of his cardiac and respiratory system revealed no abnormalities. His haemoglobin on admission to hospital was 11.8 g/dl. Prior to induction his blood pressure was 145/95 with a heart rate of 120 bpm and a Sp02 of 96%. He was pale, very anxious and stated that he was worried that he would die.
He received no premedication. Induction was commenced in the operating room. Monitoring included ECG, non-invasive automated blood pressure, pulse oximetry and capnography. Induction of anaesthesia was by inhalation with 100% oxygen at 6 IImin via a circle system with the gradual introduction of halothane up to 4%. When he was judged to be adequately anaesthetized gentle laryngoscopy was performed which revealed a small amount of clot in the tonsillar fossa and a clear pharynx. Suxamethonium 40 mg was given to facilitate intubation. Increased jaw tone followed the suxamethonium and made intubation difficult. He was intubated with a 6.0 RAE cuffed endotracheal tube.
Successful endotracheal intubation was confirmed by capnography and auscultation. Following induction BP was 110/85, HR 85 bpm, Sp02 98% and EtC0 2 54 mmHg. Anaesthesia was maintained with at racurium lO mg, N 2 0 2.0 l/min, O 2 1.0 l/min, halothane 0.5%, and intermittent positive pressure ventilation with a minute volume of 4 litres per minute. The next twenty minutes of anaesthesia were uneventful, with no tachycardia, hypoxaemia or hypercapnia. The surgery involved diathermy of the tonsillar bed with no further blood loss. Observations at this stage were BP 85/45, HR 85, Sp02 99% EtC0 2 40 mmHg.
Within the next few minutes the heart rate rose to 150 bpm and tall T waves were noted on the ECG monitor. Immediately following this some ventricular ectopic beats occurred, the Sp02 remaining at 99070. Suddenly the ectopics became multifocal and changed within seconds to VT and then VF. During this period lignocaine 50 mg IV was given plus external cardiac massage and ventilation with 100070 O 2 . The pupils were noted to be dilated. This whole sequence of events occupied less than five minutes.
Adrenaline 400 mcg was followed by several attempts at DC cardioversion at 50 to 300 joules. This was followed by 40 mmol of sodium bicarbonate, 10 ml of 10070 calcium gluconate and bretylium 200 mg IV. DC shocks were repeated with the rhythm varying between aystole and coarse VF. A right external jugular line was inserted and two units of cross-matched blood given to correct possible hypovolaemia. An adrenaline infusion was commenced via this line. Repeat doses of sodium bicarbonate 80 mmol, adrenaline 4 x 400 mcg, atropine 1.2 mg, calcium gluconate 10 ml and bretylium 200 mg were given and there were repeated attempts at DC cardioversion. After thirty minutes the monitor showed a few spontaneous beats and isoprenaline 40 mcg x 3 doses were given which resulted in a heart rate of 80 bpm and a palpable pulse. This lasted for two minutes; during this time arterial blood gases showed pH 6.632, pe02 130.2 mmHg P0 2 7.6 mmHg, HC0 3 13.7 mmolll, BE -28.7 mmolll. Asystole ensued. After another ten minutes and consultation with a senior colleague, resuscitation measures were ceased.
After this event, inquiry revealed that there was a history of leg cramps and muscle pains following a family bushwalk which required the patient to be carried around for the following days. His adenoidectomy at age five had been complicated by bleeding. He received three doses of suxamethonium and halothane at that time and had been transferred to the local paediatric hospital where it was noted that he passed "dark" urine.
Post-mortem blood contained myoglobin and a skeletal muscle CPK of 37,000 lUll. Muscle histopathology from deltoid, vastus, psoas, intercostals, and diaphragm showed evidence of at least three different episodes of muscle fibre necrosis. One set of lesions showed extensive recent muscle necrosis. Another showed collections of macro phages and groups of basophilic fibres consistent with necrosis about ten days earlier, coinciding with his anaesthetic with halothane and alcuronium. There were also areas with small fibres associated with increased fibrous tissue representing older episodes of necrosis.
A first cousin of the patient (his mother's sister's child) has subsequently been diagnosed as having Becker's Muscular Dystrophy (BMD). BMD is the most likely diagnosis in this case.
DISCUSSION
Since the early 1960s there have been case reports of myoglobinuria, rhabdomyolysis and unexpected cardiac arrest associated with the use of suxamethonium and halothane 213 • There are also less frequent reports of halothane l4 or isoflurane l5 alone causing the same problems. These case reports have the following characteristics. The affected individuals are usually children, usually male, often suffering from underlying Duchenne's Muscular Dystrophy (DMD), the effects are worse if suxamethonium follows halothane, the patient often has no prior history of any problem and the problem may be familial. There seems to be a spectrum from asymptomatic biochemical changes through frank myoglobinuria to sudden cardiac arrest. In this case the patient had a spectrum of responses from clinically undetected muscle fibre necrosis through presumed myoglobinuria to cardiac arrest and death due to acute rhabdomyolysis.
With the histology of previous muscle fibre damage and the history of severe muscle cramps following a bushwalk plus the family history of BMD, the most likely underlying diagnosis is that this boy had a mild form of muscular dystrophyl6, possibly BMD.
Becker's Muscular Dystrophy is one of a group of disorders, the dystrophinopathies, caused by abnormalities of the Xp21-linked gene that produces dystrophin17. Abnormalities of this gene, found on the X chromosome, and thus sex-linked, lead to a lack of dystrophin and its related glycoproteins. The dystrophin gene is the largest yet identified comprising over 2.5 megabases of genomic DNA l8
• It is now appreciated that due to the size of this gene there is a wide variety of mutations that can occur leading to a variety of genotypes and phenotypes amongst the dystrophinopathies I9 -2o •
The commonest recognised phenotypes are DMD with an incidence of 1:3500 19 and BMD with a similar incidence l82l • Female carriers may express the gene, usually as an asymptomatic rise in creatine kinase (CK) but may present with severe muscular dystrophy!'. Clincially the disorders present as a spectrum from normal with a raised CK through muscle cramps (like this boy) to severe muscular dystrophy present from birth". The natural history of these disorders is a worsening with time with repetitive damage to the sarcolemma leading to progressive loss of muscle fibre through necrosis. The nature of the final anaesthetic and increased susceptibility to sarcolemmal damage with age, in conjunction with the muscle damage from the previous anaesthetic nine days earlier, all would have contributed to the massive muscle necrosis that occurred.
The underlying cause of the rhabdomyolysis in this patient was clearly different to MH. In this patient Anaesthesia and Intensive Care, Vol. 22 , No. 5, October, 1994 there was no rise in EtCO z , the earliest sign of MH 22 , and in fact the EtCO z fell. This report supports the hypothesis that rhabdomyolysis due to the dystrophinopathies is a structural disorder of the sarcolemma 23 -24 and different from the metabolic disorder of MH25. Confusion arises because the final common pathway of both disorders is rhabdomyolysis 26 . There has been ongoing argument in the literature about the relationship between MH and other muscle disorders 25 . Several authors have shown contracture with caffeine in muscle from patients with DMD27-28. However there remains argument as to the meaning of these results, particularly with the use of a "skinned" muscle biopsy specimen23. In one case there was proven MH and DMD in the same pedigree 29 . Gronert has shown in two cases that dystrophic muscle does not contract in vitro in the same way as MH muscle on exposure to caffeine or halothane and argues for a difference in underlying pathology23. Further, evidence has been gathering that the underlying pathology in many of these cases of massive anaesthesia-induced rhabdomyolysis is a dystrophinopathy.
There are three converging streams of evidence. The first is the finding of the dystrophin gene and its expression-the dystrophin protein. Recent case reports of anaesthesia-induced rhabdomyolysis have been proven to have a dystrophinopathy3 (i.e. the presence of abnormal dystrophin) whereas in the past definitive diagnosis was not possible. The second stream might be regarded as one of exclusion. Tonin et apo studied 36 patients who suffered with idiopathic myoglobinuria, related to enzyme deficiencies, not associated with abnormal dystrophin. None of these patients had a personal or family history of anaesthetic problems. The third stream of evidence is that patients with muscle disorders with normal dystrophin do not get anaesthesia-induced rhabdomyolysis. Ohlendieck and colleagues 24 analysed the dystrophin content in muscle biopsies from patients with a variety of muscle disorders by immunostaining. Dystrophin protein and associated complexes are present in limb girdle dystrophy, myotonic dystrophy, fascioscapulohumeral dystrophy, oculopharyngeal muscular dystrophy, non-Fukuyama type congenital muscular dystrophy, spinal muscular atrophy and amyotrophic lateral sclerosis. None of these disorders is associated with severe anaesthesia-induced rhabdomyolysis. For example, in myotonia dystrophica (MD), despite the prolonged contractions seen with suxamethonium, severe rhabdomyolysis is not reported. However MD muscle has tested positive with the caffeine contracture tese.
These three streams of evidence, whilst not proof, nevertheless lend weight to the central role of Anaesthesia and Intensive Care, Vol. 22, No. 5, October, 1994 the dystrophinopathies III anaesthesia-induced rhabdomyolysis.
The abnormal muscle pathology found in the dystrophinopathies has recently been described in detail. The product of the dystrophin gene, dystrophin and the dystrophin related glycoproteins forms a complex which connects the cytoskeleton of the sarcolemma to the extracellular matrix24.32.33. Their absence leads to an inherent instability of the sarcolemma 24. Sarcolemmal damage is seen on electron microscopy in DMD, and the underlying pathology of the dystrophinopathies is recurrent fibre necrosis 17 . 2 '. In addition, high resting intracellular calcium has been measured in DMD which may be due to the presence of abnormal mechano-transducing ion channels 34 • Dystrophin-Iess muscle cells also show decreased osmotic stability when challenged with a hypo-osmolar medium 35 .
One hypothesis as to the mechanism of anaesthesiainduced rhabdomyolysis in patients with a dystrophinopathy is that in the presence of suxamethonium, the high resting calcium might result in a more prolonged contraction which, in the absence of proper cytoplasmic support, leads to localised failure of the sarcolemma 24 • Ionic imbalance and cellular poisoning occur leading to more extensive breakdown, rhabdomyolysis, which in turn causes hyperkalaemia and may lead to cardiac arrest. Cardiac muscle is also affected in the dystrophinopathies 17 , perhaps contributing to the intractable nature of the cardiac arrest.
In support of this hypothesis it is well established that suxamethonium causes contractions in, and damages normal muscle leading to raised serum potassium, pain, and myoglobinuria 36 . 37 • The role of the anaesthetic vapours is less clear. However it is known that suxamethonium following exposure to halothane will cause a muscle fibre to contract in vitro, whereas suxamethonium alone will not cause a contraction 38 . From case reports both halothane and isoflurane on their own have caused myoglobinuria and cardiac arrest 14 . 15 . As the complexities of ion channels and the dystrophin proteins are further investigated the exact mechanism leading to rhabdomyolysis may be elucidated.
There are several clinical implications of this case. First, this case confirms that a history of previous uneventful anaesthesia does not rule out adverse reactions in any future anaesthetic. A history of muscle cramping with normal exercise, especially in males, may be the only clue to an underlying muscle disorder 16 .
The use of suxamethonium should be limited to specific indications, especially in children 2 , and should be avoided following an inhalational induction as this appears to increase the risk of an adverse reaction 37 ,l9. This case confirms that suxamethonium and the anaesthetic vapours are contraindicated in patients with a known or suspected dystrophinopathy'"44 . This runs contrary to some early reports of anaesthesia and DMD45. However, this case reveals that patients with DMD can survive these agents but at the cost of muscle damage and risk of cardiac arrest. It is not difficult, if the diagnosis is known, to avoid suxamethonium and the anaesthetic vapours. An intravenous induction, nondepolarising relaxants and intubation, nitrous oxide and an opioid or intravenous infusion for maintenance are acceptable techniques.
Should an unexpected cardiac arrest occur in the presence of a normal end-tidal CO 2 following suxamethonium and/or the anaesthetic vapours, acute rhabdomyolysis should be suspected. No more suxamethonium or anaesthetic vapour should be given, the patient should be hyperventilated using a high fresh gas flow to remove anaesthetic vapours. Hyperventilation should be continued to reduce acidosis and plasma potassium concentration, and therapy should be directed towards assessing and treating hyperkalaemia. Dantrolene may not work, although if there is doubt about the diagnosis dantrolene should be given as it may be lifesaving, and is unlikely to do harml. Bicarbonate, calcium, and dextrose and insulin all have a role\ but with serum potassium reported above 12 mmol/JI' therapy can be extremely difficult. Blood for biochemistry and blood gases should be taken early to guide resuscitation.
Dark urine passed postoperatively should be tested for myoglobin. If myoglobin is found this may be due to an unsuspected muscle disorder and further followup is indicated.
Postoperativeiy it is important to definitively test for a dystrophinopathy in surviving patients by quantifying dystrophin levels in a muscle biopsy46 and with a direct DNA probe analysis of the gene locus 3 • In vitro muscle contracture testing should also be performed on the muscle biopsy to rule out MH as it may be clincially difficult to distinguish between the two conditions and both may rarely occur in the same patiene 9
• This patient had sufficient increased jaw tone following suxamethonium to make intubation difficult. Recommendations regarding the clinical management of isolated masseter spasm vary in the literature from continuing the anaesthetic with the inhalational agents with careful attention to monitoring 47 through to stopping the case, evaluating the extent of myoglobinuria and hyperkalaemia, attempting to rule out unsuspected neuromuscular disease, observing for fulminant MH, considering muscle biopsy and coming back another day4B. The prudent approach would seem to be to cease trigger agents, i.e. suxamethonium and the anaesthetic vapours, and hyperventilate the patient to eliminate anaesthetic vapours from the patient, then continue with a non-trigger anaesthetic while monitoring EtC0 2 , vital signs and muscle tone. Surgery should be delayed if possible for about thirty minutes to allow time to establish the diagnosis. Blood for arterial gases and biochemistry should be taken. During this time early MH should be detectable by a rise in EtC0 2 , in which case dantrolene should be given. Should unexpected cardiac arrest occur with no obvious cause, attention should be directed towards assessing and lowering blood potassium.
